Latest Close
$76.95
Stock Hub
FBRX
Forte Biosciences, Inc.
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. Use the sections below to move between chart, technical analysis, fundamentals, and news.
1y Change
$65.63 (+580.07%)
Market Cap
$1.63B
Sector
Healthcare
Industry
Biotechnology
Recommendation
hold
52W Range
$10.11 to $77.20
Target Mean Price
$73.80
Beta
2.65
Trailing P/E
Not available
Forward P/E
-19.51
Price / Book
10.23
Company Overview
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.